← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vasomune Therapeutics Inc
$9,136,352
Total funding
2
Grants
Funding over time
peak $6.4M · FY2020–21$10M$7.5M$5M$2.5M$0
'20
'21
Funding mix
By agency
DOD$9,136,352 · 2
By mechanism
—$9,136,352 · 2
Investigators at Vasomune Therapeutics Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
PHASE I & PHASE I/II CLINICAL TRIALS FOR TREATMENT OF COVID-19 ASSOCIATED ARDS BY AV-001, A NOVEL THERAPEUTIC TARGETING VASCULAR ENDOTHELIUM$6,354,825
· FY2021 · Defense Health Agency
A NOVEL TIE2 AGAINST IV MEDICATION FOR THE TREATMENT OF ALI/ARDS IN MILITARY CASUALTIES AND CIVILIANS$2,781,527
· FY2020 · Defense Health Agency